Jefferies analyst Thomas Chong raised the firm’s price target on So-Young to $2.56 from $1.20 and keeps a Buy rating on the shares. The company’s Q4 earnings beating on solid cost control, the analyst tells investors in a research note. In coming years, the firm expects SY Prime to be a key strategic focus that will reshape the medical aesthetics sector and empower providers with a one-stop solution on product offerings, store operations and branding.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SY: